Summary
Copart, Inc. (CPRT) filed a Form 8-K on March 11, 2003, to report the adoption of a Preferred Stock Rights Agreement, effective March 6, 2003. This agreement declared a dividend of one 'Right' for each outstanding common share, entitling holders to purchase one one-thousandth of a share of Series A Participating Preferred Stock at a specified exercise price. These Rights will become exercisable upon a 'Distribution Date,' triggered by an entity acquiring 15% or more of Copart's common stock or announcing a tender offer that would lead to such ownership. The primary purpose of this 'poison pill' is to deter hostile takeovers by making them prohibitively expensive or dilutive to an unwanted acquirer, thereby protecting shareholder value and the Board's ability to negotiate beneficial transactions. The Rights are not intended to prevent all takeovers but to provide the Board with leverage in unsolicited acquisition attempts. They will not interfere with mergers or business combinations approved by the Board and do not currently impact the company's financial strength or trading. The Rights are redeemable by the company for a nominal amount prior to the trigger event, and they will not be separately tradable or exercisable until the Distribution Date. Shareholders should note that the Rights do not grant any shareholder rights, such as voting or dividends, until exercised.
Key Highlights
- 1Copart adopted a Preferred Stock Rights Agreement on March 6, 2003, effective March 10, 2003.
- 2A dividend of one 'Right' per common share was declared, exercisable on or after a 'Distribution Date'.
- 3The 'Distribution Date' is triggered if an acquirer obtains beneficial ownership of 15% or more of Copart's common stock.
- 4Upon trigger, Rights holders can purchase Series A Participating Preferred Stock at an exercise price, or potentially acquire target company shares in a merger.
- 5The agreement is intended as an anti-takeover measure to protect shareholder value from unsolicited attempts.
- 6The Rights are redeemable by the company for $0.001 per Right prior to the trigger event.
- 7The Rights do not currently affect Copart's financial strength, business plans, or EPS and are not taxable to shareholders.